Impact of Hidradenitis Suppurativa on Quality of Life Functions
1 other identifier
observational
400
1 country
1
Brief Summary
The goal of this study is to get a better understanding of the impact of Hidradenitis Suppurativa (HS) on the quality of life of patients with this condition. Patients with HS will be asked questions about demographics including gender, age, and ethnicity. They will also be asked to complete questionnaires to determine how their skin condition affects their life. Study participation will last for 1 day, with potential for follow-up in the future. We hope this information will help us improve our treatment for this skin condition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 11, 2017
CompletedFirst Posted
Study publicly available on registry
September 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 6, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 6, 2022
CompletedJanuary 20, 2023
January 1, 2023
7.4 years
September 11, 2017
January 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Dermatology-related quality of life
Quality of life as measured using standardized Dermatology Quality of Life Index
Baseline
Presence and severity of depression
Presence and severity of depression as measured using standardized Beck Depression Inventory
Baseline
Dermatology-related quality of life
Quality of life as measured using standardized SkinDex questionnaires
Baseline
Subject-reported subject health
Subject-reported subject health as measured using standardized SF-36 questionnaires
Baseline
Degree of enjoyment and satisfaction experienced by subjects in daily functioning.
Degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning as measured by the standardized Quality of Life Enjoyment and Satisfaction Questionnaire-short form.
Baseline
Employment and economic productivity
Self-reported employment and economic productivity as measured by a standardized health economic questionnaire
Baseline
Secondary Outcomes (6)
Change in quality of life
At 6 months
Change in presence and severity of depression as measured using standardized Beck Depression Inventory
At 6 months
Change in quality of life
At 6 months
Change in subject-reported subject health
At 6 months
Change in degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning
At 6 months
- +1 more secondary outcomes
Study Arms (1)
Hidradenitis Suppurativa Cohort
Patients with HS who are eligible to fill out the series of quality of life questionnaires
Eligibility Criteria
Healthy adults (ages 18-99) who have a diagnosis of HS (as deemed by a physician at the Hidradenitis Suppurativa Treatment Center at Montefiore Medical Center)
You may qualify if:
- Clinical diagnosis of hidradenitis suppurativa
- Subject age \>/= 18 years
- Able to be evaluated by a Montefiore physician
You may not qualify if:
- No clinical diagnosis of hidradenitis suppurativa
- Subject age \< 18 years
- Subject unable to understand or answer provided questionnaires
- Unable to evaluated by a Montefiore physician
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Montefiore Medical Centerlead
- AbbViecollaborator
Study Sites (1)
Montefiore Medical Center
The Bronx, New York, 10467, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Cohen, MD. MPH
Momtefiore Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2017
First Posted
September 20, 2017
Study Start
April 1, 2015
Primary Completion
September 6, 2022
Study Completion
September 6, 2022
Last Updated
January 20, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share
There are no plans to share individual participant data to other researchers